These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16382298)

  • 1. Dipyridamole, an underestimated vascular protective drug.
    Schaper W
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):357-63. PubMed ID: 16382298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?
    Balakumar P; Nyo YH; Renushia R; Raaginey D; Oh AN; Varatharajan R; Dhanaraj SA
    Pharmacol Res; 2014 Sep; 87():144-50. PubMed ID: 24861566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angina pectoris induced by oral dipyridamol].
    Fernández C; Bonilla B; Giner V; Llopis R
    Med Clin (Barc); 2001 Jul; 117(6):238. PubMed ID: 11481101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 5. Dipyridamole with aspirin for secondary stroke prevention.
    Norrving B
    Lancet; 2006 May; 367(9523):1638-9. PubMed ID: 16714170
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
    Almdal TP; Eldrup E; Godtfredsen J; Kofoed-Enevoldsen A
    Ugeskr Laeger; 1999 Aug; 161(34):4771-2. PubMed ID: 10500471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis.
    Picano E; Michelassi C
    Cardiovasc Res; 1997 Mar; 33(3):666-70. PubMed ID: 9093537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole in antithrombotic treatment.
    Eisert WG
    Adv Cardiol; 2012; 47():78-86. PubMed ID: 22906904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials and dipyridamole formulation selection.
    Derendorf H
    Cerebrovasc Dis; 2007; 23(1):72-3; author reply 73-4. PubMed ID: 17108677
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty.
    Finocchiaro ML; Buffon A; Beltrame JF; Lupi A; Conti E; Lanza GA; Cianflone D; Crea F; Maseri A
    Coron Artery Dis; 1995 Jun; 6(6):479-87. PubMed ID: 7551269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
    Haberl R
    MMW Fortschr Med; 2003 May; 145 Suppl 2():98. PubMed ID: 14579496
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R; French L
    J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
    [No Abstract]   [Full Text] [Related]  

  • 18. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Rosendaal FR; Algra A
    J Neurol Sci; 1997 Sep; 150(1):85, 87. PubMed ID: 9260863
    [No Abstract]   [Full Text] [Related]  

  • 19. Dipyridamole protects the liver against warm ischemia and reperfusion injury.
    Taniguchi M; Magata S; Suzuki T; Shimamura T; Jin MB; Iida J; Furukawa H; Todo S
    J Am Coll Surg; 2004 May; 198(5):758-69. PubMed ID: 15110810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine.
    Heidland UE; Heintzen MP; Schwartzkopff B; Strauer BE
    Am Heart J; 2000 Nov; 140(5):813-20. PubMed ID: 11054630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.